Genway Biotech, LLC
Aviva Systems Biology Corporation Part of Aviva Systems Biology Corporation
- UEI
- Q7KGV5SPMHU6
- CAGE
- 3DV35
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Y5SMULKWLR96
-
Parent
Y5SMULKWLR96
- SAM.gov registration date
- Website
- genwaybio.com
- Founded
- 1998
- Employees
- 11-50
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Latest 5 listed here. See the rest on GovTribe.
SBA capabilities narrative
We use gene-specific antibodies to discover and validate important proteins: drug targets, disease biomarkers, therapeutic proteins and antibodies. We offer a wide range of antibody, protein, antigen and other biological products and services.
Quick answers
Is Genway Biotech, LLC registered in SAM.gov?
Genway Biotech, LLC's SAM.gov registration expired on July 31, 2026.
What is Genway Biotech, LLC's most recent federal award?
Genway Biotech, LLC's most recent federal contract award is Human varicella zoster IGG elisa assay k - vaccines (HT001418P0244), from Defense Health Agency, on May 29, 2018.
On GovTribe
See Genway Biotech, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors